Kymera Therapeutics Inc. (KYMR)
Market Closed
17 Jul, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary 
XKLS $
115. 77
+1.78
+1.5615%
$
9.22B Market Cap
- P/E Ratio
- Div Yield
720,700 Volume
-2.54 Eps
$ 113.99
Previous Close 
Want to track KYMR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Kymera Therapeutics Inc. (KYMR) Statistics
Valuation metrics
Market Cap 9.22B
Enterprise value 9.46B
Trailing P/E (ttm) -32.34
Forward P/E -
PEG ratio 2.17
Price/Sales (ttm) 185.04
Price/Book (mrq) 7.33
Enterprise Value/Revenue 183.8
Enterprise Value/EBITDA -30.91
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 714.39K
Average volume (90 days) 566.97K
Price summary
52-Week low 36.65
52-Week high 130.05
Beta -
50-Day moving average 97.24
200-Day moving average 82.09
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -6.12%
Operating margin -6.98%
Operational effectiveness
Return on assets -0.19%
Return on equity -0.25%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.53
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -3.23
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 6.67
Total debt (mrq) -
Total Debt/Equity (mrq) 0.05
Current ratio (mrq) 10.81%
Book value per share (mrq) 15.79
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
